A comparison of antimicrobial usage in human and veterinary medicine in France from 1999 to 2005.
OBJECTIVE
The antimicrobials allowed and amounts sold in veterinary and human medicine in France were compared to see if the same antimicrobial drugs are used in veterinary and human medicine, and to the same extent.


METHODS
Registers of all approved antimicrobial commercial products, kept by the French Agency for Veterinary Medicinal Products (AFSSA ANMV) for animals and the French Health Products Safety Agency (AFSSAPS) for humans, were compared to determine whether the same antimicrobials were approved in 2007 for use in both human and animal populations. Sales data were collected from pharmaceutical companies between 1999 and 2005 by the AFSSA ANMV and AFSSAPS. Usage of the different antimicrobial anatomical therapeutic chemical (ATC) classes in human and veterinary medicines was recorded. Data were expressed in tonnes of active ingredients and were then related to the animal and human biomasses to compare usages expressed in mg/kg.


RESULTS
All antimicrobial ATC classes were used in both human and veterinary medicine. Tetracyclines accounted for the most sales in veterinary medicine. beta-Lactams predominated in human medicine. A decrease in the amounts consumed by both human and animal populations was observed during the study. In 2005, 760 tonnes were used in human medicine and 1320 tonnes in veterinary medicine, corresponding to 199 and 84 mg/kg of live weight in human and animal populations, respectively.


CONCLUSIONS
The same antimicrobial drugs were used in human and veterinary medicines but the quantitative patterns of use were different. Expression of antimicrobial usage is a key point to address when comparing usage trends.
Moulin
Gérard
G
AFSSA ANMV French Agency for Veterinary Medicinal Products, Fougères, France.
Cavalié
Philippe
P
Pellanne
Isabelle
I
Chevance
Anne
A
Laval
Arlette
A
Millemann
Yves
Y
Colin
Pierre
P
Chauvin
Claire
C
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D019072:Antibiotic Prophylaxis / Q000706:statistics & numerical data*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000517:prevention & control*; D004363:Drug Utilization / Q000706:statistics & numerical data; D005602:France; D006801:Humans; D008511:Medicine / Q000706:statistics & numerical data*; D014730:Veterinary Medicine / Q000706:statistics & numerical data*
D000900:Anti-Bacterial Agents